BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34789552)

  • 1. Activated but impaired IFN-γ production of mucosal-associated invariant T cells in patients with hepatocellular carcinoma.
    Huang W; Ye D; He W; He X; Shi X; Gao Y
    J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34789552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol Abstinence Does Not Fully Reverse Abnormalities of Mucosal-Associated Invariant T Cells in the Blood of Patients With Alcoholic Hepatitis.
    Li W; Lin EL; Liangpunsakul S; Lan J; Chalasani S; Rane S; Puri P; Kamath PS; Sanyal AJ; Shah VH; Radaeva S; Crabb DW; Chalasani N; Yu Q
    Clin Transl Gastroenterol; 2019 Jun; 10(6):e00052. PubMed ID: 31211759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal-associated invariant T-cells are severely reduced and exhausted in humans with chronic HBV infection.
    Huang W; He W; Shi X; Ye Q; He X; Dou L; Gao Y
    J Viral Hepat; 2020 Nov; 27(11):1096-1107. PubMed ID: 32510704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human MAIT cells endowed with HBV specificity are cytotoxic and migrate towards HBV-HCC while retaining antimicrobial functions.
    Healy K; Pavesi A; Parrot T; Sobkowiak MJ; Reinsbach SE; Davanian H; Tan AT; Aleman S; Sandberg JK; Bertoletti A; Sällberg Chen M
    JHEP Rep; 2021 Aug; 3(4):100318. PubMed ID: 34377970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral loss of CD8(+) CD161(++) TCRVα7·2(+) mucosal-associated invariant T cells in chronic hepatitis C virus-infected patients.
    Barathan M; Mohamed R; Vadivelu J; Chang LY; Saeidi A; Yong YK; Ravishankar Ram M; Gopal K; Velu V; Larsson M; Shankar EM
    Eur J Clin Invest; 2016 Feb; 46(2):170-80. PubMed ID: 26681320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyper-Expression of PD-1 Is Associated with the Levels of Exhausted and Dysfunctional Phenotypes of Circulating CD161
    Yong YK; Saeidi A; Tan HY; Rosmawati M; Enström PF; Batran RA; Vasuki V; Chattopadhyay I; Murugesan A; Vignesh R; Kamarulzaman A; Rajarajeswaran J; Ansari AW; Vadivelu J; Ussher JE; Velu V; Larsson M; Shankar EM
    Front Immunol; 2018; 9():472. PubMed ID: 29616020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated and Exhausted MAIT Cells Foster Disease Progression and Indicate Poor Outcome in Hepatocellular Carcinoma.
    Duan M; Goswami S; Shi JY; Wu LJ; Wang XY; Ma JQ; Zhang Z; Shi Y; Ma LJ; Zhang S; Xi RB; Cao Y; Zhou J; Fan J; Zhang XM; Gao Q
    Clin Cancer Res; 2019 Jun; 25(11):3304-3316. PubMed ID: 30723143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease of CD69 levels on TCR Vα7.2
    Yong YK; Tan HY; Saeidi A; Rosmawati M; Atiya N; Ansari AW; Rajarajeswaran J; Vadivelu J; Velu V; Larsson M; Shankar EM
    Innate Immun; 2017 Jul; 23(5):459-467. PubMed ID: 28606013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Increased expressions of programmed death 1 (PD-1) and its ligands in peripheral CD3(+) T cells and CD19(+) B cells in patients with hepatocellular carcinoma].
    Liu W; Chai L; Liang J; Lu Z; Yang S
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Sep; 32(9):1243-7. PubMed ID: 27609582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL12-CXCR4-Mediated Chemotaxis Supports Accumulation of Mucosal-Associated Invariant T Cells Into the Liver of Patients With PBC.
    Chen Z; Liu S; He C; Sun J; Wang L; Chen H; Zhang F
    Front Immunol; 2021; 12():578548. PubMed ID: 33815355
    [No Abstract]   [Full Text] [Related]  

  • 11. Activation, Deficiency, and Reduced IFN-γ Production of Mucosal-Associated Invariant T Cells in Patients with Inflammatory Bowel Disease.
    Ju JK; Cho YN; Park KJ; Kwak HD; Jin HM; Park SY; Kim HS; Kee SJ; Park YW
    J Innate Immun; 2020; 12(5):422-434. PubMed ID: 32535589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAIT cells are chronically activated in patients with autoimmune liver disease and promote profibrogenic hepatic stellate cell activation.
    Böttcher K; Rombouts K; Saffioti F; Roccarina D; Rosselli M; Hall A; Luong T; Tsochatzis EA; Thorburn D; Pinzani M
    Hepatology; 2018 Jul; 68(1):172-186. PubMed ID: 29328499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The possible role of CD8+/Vα7.2+/CD161++ T (MAIT) and CD8+/Vα7.2+/CD161
    Meggyes M; Szanto J; Lajko A; Farkas B; Varnagy A; Tamas P; Hantosi E; Miko E; Szereday L
    Am J Reprod Immunol; 2018 Feb; 79(2):. PubMed ID: 29265516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Impaired Vα7.2+CD161++CD8+ (MAIT) and Vα7.2+CD161-CD8+ T-Cell Populations and Gut Dysbiosis in Chronically HIV- and/or HCV-Infected Patients.
    Merlini E; Cerrone M; van Wilgenburg B; Swadling L; Cannizzo ES; d'Arminio Monforte A; Klenerman P; Marchetti G
    Front Microbiol; 2019; 10():1972. PubMed ID: 31555223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal-associated invariant T cells are reduced and functionally immature in the peripheral blood of primary Sjögren's syndrome patients.
    Wang JJ; Macardle C; Weedon H; Beroukas D; Banovic T
    Eur J Immunol; 2016 Oct; 46(10):2444-2453. PubMed ID: 27461134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal associated invariant T cells from human breast ducts mediate a Th17-skewed response to bacterially exposed breast carcinoma cells.
    Zumwalde NA; Haag JD; Gould MN; Gumperz JE
    Breast Cancer Res; 2018 Sep; 20(1):111. PubMed ID: 30208917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-Hepatic Depletion of Mucosal-Associated Invariant T Cells in Hepatitis C Virus-Induced Liver Inflammation.
    Bolte FJ; O'Keefe AC; Webb LM; Serti E; Rivera E; Liang TJ; Ghany M; Rehermann B
    Gastroenterology; 2017 Nov; 153(5):1392-1403.e2. PubMed ID: 28780074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis.
    Miyazaki Y; Miyake S; Chiba A; Lantz O; Yamamura T
    Int Immunol; 2011 Sep; 23(9):529-35. PubMed ID: 21712423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD161 Expression on Mucosa-Associated Invariant T Cells is Reduced in HIV-Infected Subjects Undergoing Antiretroviral Therapy Who Do Not Recover CD4
    Freeman ML; Morris SR; Lederman MM
    Pathog Immun; 2017; 2(3):335-351. PubMed ID: 28868514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.